LizarBio Therapeutics

About:

Pre Clinical Stage Company working with Advanced Cell Therapies to cure incurable diseases using cells.

Top Investors: IndieBio, SOSV, Kria, Libbs Farmacêutica

Description:

LizarBio Therapeutics is developing the first of its kind plataform to produce any cell type in the body at industrial scale (>100L). By reimagining cell culture media from the ground up, we have developed negligible-cost media to cultivate and differentiate pluripotent stem cells for therapeutic applications. Currently, we are developing two cellulat therapies focused on two key areas, namely: cardiology and neurology.

Total Funding Amount:

$1.75M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Dover, Delaware, United States

Founded Date:

2013-01-01

Contact Email:

contact(AT)lizar.bio

Founders:

Diogo G Biagi, Marcos Valadares

Number of Employees:

11-50

Last Funding Date:

2022-03-07

IPO Status:

Private

Industries: